Effects of Aronia Berry on Inflammation in COPD Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of freeze-dried aronia berry consumption on inflammatory markers in patients with chronic obstructive pulmonary disease (COPD). Conducted at a research hospital in Istanbul, 50 participants aged 50-80 will be randomly assigned to receive either aronia berry powder or a placebo for 8 weeks. The study will assess various respiratory, biochemical, and anthropometric parameters before and after the intervention, alongside dietary intake records. The aim is to determine if aronia berries can serve as an effective adjunct to standard medical treatment for COPD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 50-80 years
* Diagnosed with COPD
* Not following a vegetarian or vegan diet
* Willing to consume the provided aronia berry (black chokeberry)
* Non-smokers
* Have signed the informed consent form
* Has not undergone endobronchial tube or valve surgery in the last two years.

Exclusion Criteria:

* Presence of associated chronic inflammatory/rheumatic diseases
* Chronic infections that may create a prothrombotic state
* Chronic kidney disease (CKD)
* Malignancy
* Hereditary thrombophilia
* Essential thrombocythemia
* Diagnosed endocrine disorders
* Malabsorption disorders
* Allergy to any food or berry fruits
* Smoking
* Participants who did not sign the informed consent form

Where it's running

• Yedikule Göğüs Hastalıkları Hastanesi
  Istanbul, Zeytinburnu, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Buse Sarıkaya, PhD
• Email: buse-sarikaya@hotmail.com
• Phone: 05544615101

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enhanced COPD care for people being checked for lung cancer

  This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.

  Recruiting Region of Southern Denmark · Vejle · NCT07543601

• High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia

  This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.

  Recruiting Mansoura University · Al Mansurah, Dakahlia Governorate · NCT07854210

• Risk-based lung cancer screening in COPD patients using ML and clinical models

  This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.

  Recruiting Vejle Hospital · Vejle, Region Syddanmark · NCT07848815

• Biologics for Type 2 Inflammation in Asthma and COPD in Real World

  This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.

  Recruiting Shanghai Pulmonary Hospital, Shanghai, China · Shanghai, Shanghai Municipality · NCT07823842

• Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers

  This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.

  Recruiting at 2 sites Phase 4 COPD Foundation · Saint Charles, Missouri and 1 other locations · NCT07816835

• New breathing tests to diagnose airway disease in hospital and community settings

  This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.

  Recruiting University Hospital Southampton NHS Foundation Trust · Andover, Hampshire and 1 other locations · NCT07798596

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.